All blog posts
Total 25 results for
Showing 12 out of 25 results
08 December 2020
As the Bundestag passes the legislation to ratify the UPC Agreement, the UPC may finally open its doors in 2022
17 September 2020
Glaxo’s purple inhalers fail to get trade mark protection
11 September 2020
The Unified Patent Court - on the move again?
12 May 2020
Patent and Pharma Update, May 2020
06 May 2020
Update on medicines and medical devices regulation in the EU and the UK and the impact of COVID-19
30 April 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
22 April 2020
The UK will not participate in the UPC confirms IP Minister responding to House of Lords' letter
08 April 2020
COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)
08 April 2020
COVID-19: Pressure Points: A Catalyst for Collaboration (Global)
03 April 2020
COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)
03 April 2020
UK HC confirms that public interest grounds to refuse or limit an injunction to be used sparingly
30 March 2020
What’s next for the UPC project? Our analysis following the German Federal Constitutional Court decision
Showing 12 out of 25 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris, Korea Group and Africa Group
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London